intellectual property

Disney stock down 51% offers compelling value as streaming turns profitable with $1.3B operating income and experiences maintain 33% margins, trading at 14.5x P/E versus Netflix's 37.7x.

AIM ImmunoTech ($AIMT) surged 73.66% after securing Japanese patent approval for Ampligen cancer therapy through 2039, strengthening its immuno-oncology portfolio.

Lightbridge Corporation received patent approval from Canadian authorities for innovative helically twisted fuel assembly technology applicable to CANDU reactors and small modular reactors.

Global IP management software market projected to grow 11.79% annually from $9.045B in 2025 to $17.649B by 2031, driven by patent filings and regulatory complexity.

Anixa Biosciences secures patent protection in South Korea for breast cancer vaccine technology, advancing its IP portfolio as Phase 1 trial shows 74% immune response rate.

Disciplined Growth Investors reduces InterDigital stake by $64.3M after 70% stock surge, trimming position from 4.95% to 3.71% of assets while maintaining $193.9M exposure.

Mangoceuticals files PCT patent application for MGX-0024 antiviral additive, following clinical trials showing zero mortality in 29,000 birds against H5N1 avian influenza.

American Fusion files 20 Texatron patent applications, with 240 more planned through 2026, totaling approximately 260 applications to protect its aneutronic fusion technology.

BioNTech sues Moderna for patent infringement over next-gen COVID vaccine technology, claiming mNEXSPIKE violates its spike protein patents. Seeking damages for unlicensed use.

Munich court grants InterDigital fifth injunction against Disney over HEVC video patent infringement. The ruling escalates their IP dispute, potentially impacting Disney's content distribution.